Skip to content

Raw materials at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$83.33M+37.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$89K0.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$2.61M-13.7%
ALN
Alnylam PharmaceuticalsALNY
$11.69M-50.0%
AbbVie logo
AbbVieABBV
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's raw materials?
Aurinia Pharmaceuticals (AUPH) reported raw materials of $658K in Q1 2026.
How has Aurinia Pharmaceuticals's raw materials changed year-over-year?
Aurinia Pharmaceuticals's raw materials decreased by 14.7% year-over-year, from $771K to $658K.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.